Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2022-01-05 00:00:00 ET · period of report 2022-01-03 · accession 0001765581-22-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-05 | 2022-01-03 | JAZZ | Swisher Daniel N JR | Pres, COO | F - Tax | $131.01 | -1,624 | 48.5K | -3% | -$212.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-01-03 | F | D | 1,624 | $131.01 | 48,546 | D | — | — | (F2) Includes 147 and 62 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 28 and November 30, 2021, respectively. |